U.S. Congress Debates FY2026 Counterfentanyl Funding With Conditions on Mexico Cooperation

The U.S. House Appropriations Committee's proposed FY2026 appropriation includes $175 million to counter fentanyl globally — an increase over the Trump administration's $125 million request — but would withhold 30% of counternarcotics assistance to Mexico until specific security-related conditions are met. The conditionality provision reflects Congressional frustration with Mexico's response to cartel operations and the fentanyl crisis. U.S. overdose deaths from synthetic opioids reached 48,422 in 2024, down from 76,282 in 2023, a decline some analysts attribute to supply disruptions from the Sinaloa civil war and intensified DEA operations. CJNG, designated a Foreign Terrorist Organization by the Trump administration in February 2025, remains the primary focus of counterfentanyl operations. The Brookings Institution's Vanda Felbab-Brown has warned that funding conditionality risks damaging the intelligence-sharing relationship that enabled the February 22 Tapalpa operation — the single largest anti-cartel strike in Mexican history.